V6 Rear Case Assembly, Product Code 35701, a replacement part for the SIGMA Spectrum Infusion Pum...

FDA Device Recall #Z-0672-2017 — Class II — September 28, 2016

Recall Summary

Recall Number Z-0672-2017
Classification Class II — Moderate risk
Date Initiated September 28, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Baxter Healthcare Corp.
Location Deerfield, IL
Product Type Devices
Quantity 439 units

Product Description

V6 Rear Case Assembly, Product Code 35701, a replacement part for the SIGMA Spectrum Infusion Pump -- SIGMA LLC Medina, NY 14103 --- NOTE: The speakers are a part of the rear case assembly located in the back of the infusion pump. The speaker is intended to generate audible tones during each keystroke, and during alarm conditions. However, some speakers have a variation in their internal wiring that increases the potential for the speaker to fail prematurely. Spectrum Infusion Pumps with non-functional speakers will continue to display visual alarm indications, and will otherwise continue to operate as intended. Product Code 35701 is a replacement assembly that is shipped to customers for self-repair of the Spectrum Infusion Pump. It is not a registered finished good.

Reason for Recall

A correction was issued for the SIGMA Spectrum Infusion Pump with Master Drug Library and Rear Case Assembly in order to replace speakers installed in pumps or included in spare part rear case assemblies that have an increased potential to fail prematurely.

Distribution Pattern

Nationwide Distribution, Puerto Rico and Canada

Lot / Code Information

Product Code 35701; distributed between 02/04/2015 - 06/02/2015.

Other Recalls from Baxter Healthcare Corp.

Recall # Classification Product Date
Z-0370-2017 Class II GAMBRO Capillary Dialyzer, Polyflux(R) Revaclea... Oct 12, 2016
Z-0671-2017 Class II Baxter SIGMA Spectrum INFUSION PUMP with Master... Sep 28, 2016
Z-0670-2017 Class II sigma spectrum VOLUMETRIC INFUSION PUMP with Ma... Sep 28, 2016
Z-2533-2016 Class II Synovis VASCU-GUARD Peripheral Vascular Patch i... Jun 24, 2016
Z-2049-2016 Class II PrismaSate BGK2/0 Dialysis Solution for Continu... May 23, 2016

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.